Literature DB >> 15840090

Interferon-gamma is a potent inducer of catagen-like changes in cultured human anagen hair follicles.

T Ito1, N Ito, M Saathoff, A Bettermann, M Takigawa, R Paus.   

Abstract

BACKGROUND: Interferon (IFN)-gamma appears to be an important hair cycle modulator in mice. It is unclear whether it has similar hair growth modulatory functions in human hair follicles.
OBJECTIVES: To study whether IFN-gamma can be exploited to modulate the growth, pigmentation and/or cycling of organ-cultured human anagen scalp hair follicles, as an in vitro indicator system for how IFN-gamma affects human hair growth in vivo. This was correlated with the hair follicle expression patterns of IFN-gamma receptors alpha and beta. In addition, we wanted to establish a new, simple tool for the rapid experimental induction of catagen in vitro.
METHODS: Normal human scalp hair follicles in the anagen VI stage of the hair cycle were cultured according to the method of Philpott et al., with or without IFN-gamma (50-1000 IU mL(-1)). Hair shaft elongation and pigmentation changes were measured, complemented by quantitative histomorphometry to assess changes in hair follicle cycling (hair cycle score), proliferation (Ki-67), melanogenesis (Masson-Fontana) and apoptosis (TUNEL). IFN-gamma receptors were also localized by immunofluorescence and EnVision technique. As transforming growth factor (TGF)-beta2 is a recognized key inducer of catagen in human hair follicles, TGF-beta2 expression was investigated by tyramide signal amplification and reverse transcription-polymerase chain reaction in anagen hair follicles treated with vehicle (phosphate-buffered saline) or IFN-gamma.
RESULTS: IFN-gamma rapidly inhibited hair elongation in cultured human anagen hair follicles and induced morphological signs of catagen transformation after only 4 days of culture, i.e. faster than with other reported catagen-inducers (e.g. TGF-beta2). Proliferation was inhibited, apoptosis was increased and follicular melanogenesis was switched off in hair bulb keratinocytes treated in situ with IFN-gamma. Anagen hair follicles displayed strong IFN-gamma receptor alpha-like immunoreactivity, while the immunoreactivity for IFN-gamma receptor beta in the hair matrix was only weak. TGF-beta2 immunoreactivity and mRNA transcript levels were enhanced in hair follicles treated with IFN-gamma.
CONCLUSIONS: These data suggest that IFN-gamma is a potent catagen inducer in normal human scalp hair follicles, which express cognate receptors, and show that IFN-gamma administration offers an excellent tool for experimental catagen induction in organ-cultured human hair follicles. This catagen induction probably occurs at least in part via upregulation of the recognized catagen-stimulatory growth factor TGF-beta2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840090     DOI: 10.1111/j.1365-2133.2005.06453.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  32 in total

1.  Suppression of melanin production by expression of HSP70.

Authors:  Tatsuya Hoshino; Minoru Matsuda; Yasuhiro Yamashita; Masaya Takehara; Masayo Fukuya; Kazutaka Mineda; Daisuke Maji; Hironobu Ihn; Hiroaki Adachi; Gen Sobue; Yoko Funasaka; Tohru Mizushima
Journal:  J Biol Chem       Date:  2010-02-22       Impact factor: 5.157

Review 2.  Lymphocytes, neuropeptides, and genes involved in alopecia areata.

Authors:  Amos Gilhar; Ralf Paus; Richard S Kalish
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

Review 3.  A Clinical and Biological Guide for Understanding Chemotherapy-Induced Alopecia and Its Prevention.

Authors:  Christopher John Dunnill; Wafaa Al-Tameemi; Andrew Collett; Iain Stuart Haslam; Nikolaos Theodoros Georgopoulos
Journal:  Oncologist       Date:  2017-09-26

4.  Hot water extract of oriental melon leaf promotes hair growth and prolongs anagen hair cycle: In vivo and in vitro evaluation.

Authors:  Long-Quan Pi; Won-Soo Lee; Sung Hee Min
Journal:  Food Sci Biotechnol       Date:  2016-04-30       Impact factor: 2.391

5.  CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata.

Authors:  Zhenpeng Dai; Luzhou Xing; Jane Cerise; Eddy Hsi Chun Wang; Ali Jabbari; Annemieke de Jong; Lynn Petukhova; Angela M Christiano; Raphael Clynes
Journal:  J Immunol       Date:  2016-07-13       Impact factor: 5.422

6.  A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control.

Authors:  Eniko Bodó; Tamás Bíró; Andrea Telek; Gabriella Czifra; Zoltán Griger; Balázs I Tóth; Alessandra Mescalchin; Taisuke Ito; Albrecht Bettermann; László Kovács; Ralf Paus
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

7.  Human scalp hair follicles are both a target and a source of prolactin, which serves as an autocrine and/or paracrine promoter of apoptosis-driven hair follicle regression.

Authors:  Kerstin Foitzik; Karoline Krause; Franziska Conrad; Motonobu Nakamura; Wolfang Funk; Ralf Paus
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

8.  A meeting of two chronobiological systems: circadian proteins Period1 and BMAL1 modulate the human hair cycle clock.

Authors:  Yusur Al-Nuaimi; Jonathan A Hardman; Tamás Bíró; Iain S Haslam; Michael P Philpott; Balázs I Tóth; Nilofer Farjo; Bessam Farjo; Gerold Baier; Rachel E B Watson; Benedetto Grimaldi; Jennifer E Kloepper; Ralf Paus
Journal:  J Invest Dermatol       Date:  2013-09-04       Impact factor: 8.551

9.  Gsdma3 gene is needed for the induction of apoptosis-driven catagen during mouse hair follicle cycle.

Authors:  Mingxing Lei; Xiang Gao; Li Yang; Tian Yang; Xiaohua Lian
Journal:  Histochem Cell Biol       Date:  2011-07-30       Impact factor: 4.304

Review 10.  Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.

Authors:  Amos Gilhar; Adam G Schrum; Amos Etzioni; Herman Waldmann; Ralf Paus
Journal:  Autoimmun Rev       Date:  2016-03-10       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.